XML 58 R5.htm IDEA: XBRL DOCUMENT v3.26.1
Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Operating expenses:    
Research and development expenses $ 6,266 $ 2,811
General and administrative expenses 1,555 1,541
Total operating expenses 7,821 4,352
Operating loss (7,821) (4,352)
Other expense – direct listing offering costs (1,164)
Other expense – recapitalization of common stock (26,004)
Net loss and comprehensive loss $ (8,985) $ (30,356)
Net loss per share – basic $ (0.2) $ (0.89)
Net loss per share – diluted $ (0.2) $ (0.89)
Weighted average common shares outstanding – basic 45,422,581 34,200,660
Weighted average common shares outstanding – diluted 45,422,581 34,200,660